SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-148082
Filing Date
2022-05-12
Accepted
2022-05-12 07:30:56
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d337665d8k.htm   iXBRL 8-K 25228
2 EX-99.1 d337665dex991.htm EX-99.1 51463
6 GRAPHIC g337665g19h42.jpg GRAPHIC 10631
  Complete submission text file 0001193125-22-148082.txt   221746

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sybx-20220512.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20220512_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20220512_pre.xml EX-101.PRE 11280
8 EXTRACTED XBRL INSTANCE DOCUMENT d337665d8k_htm.xml XML 3360
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 22915727
SIC: 2834 Pharmaceutical Preparations